Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1367-1374

  Uberti, F ^a   Lattuada, D ^a   Morsanuto, V ^a,c   Nava, U ^a   Bolis, G ^b   Vacca, G ^c   Squarzanti, D F ^c   Cisari, C ^c   Molinari, C ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; AUTOPHAGY; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 84898441458     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2103     Document Type: Article

References (38)

1. Martinesi M, Bruni S, Stio M, Treves C. 1,25-DihydroxyvitaminD3 inhibits tumor necrosis factor-a-induced adhesion molecule expression in endothelial cell. Cell Biol Int. 2006;30(4):365-375.
2. Talmor Y, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts pro-atherosclerotic parameters through NFKB and p38 in vitro. Eur J Clin Invest. 2008;38(8):548-554.
3. Park CW, Oh YS, Shin YS, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999;33:73-81.
4. Shoji T, Shinohara K, Kimoto E, et al. Lower risk for cardiovascular mortality in oral la-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant. 2004;19:179-184.
5. Talmor Y, Golan E, Benchetrit S, Berheim J, Klein O, Green J. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol. 2008; 294:F1059-Fl 064.
6. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325-349.
7. Wu-Wong JR, Kawai M, Chen YW, Nakane M. VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects. Br J Pharmacol. 2011;164:551-560.
8. Thompson L, Wang A, Tawfik O, et al. Effects of 25-hydroxyvitamin D3 and 1a,25 dihydroxyvitamin D3 on differentiation and ap-optosis of human osteosarcoma cell lines. J Orthop Res. 2012;30(5): 831-844.
9. Somjen D, Kohen F, Amir-Zaltsman, Knoll E, Stern N. Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. Am J Hypertens. 2000;13(4 Pt 1):396-403.
10. Norman AW. Vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542-5548.
11. Boland R, Buitrago C, Russo De Boland A. Modulation of tyrosine phosphorylation signalling pathways by la,25(OH) 2-vitamin D3. Trends Endocrinol Metab. 2005;16(6):280-287.
12. Zehnder D, Bland R, Chana RS, et al. Synthesis of 1,25-dihy-droxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13(3):621-629.
13. Xiang W,He XJ, Ma YL, etal. 1,25(OH) 2D3 influences endothelial cell proliferation, apoptosis and endothelial nitric oxide synthase expression of aorta in apoliprotein E-deficient mice [in Chinese]. Zhonghua Er Ke Za Zhi. 2011;49(11):829-833.
14. Kanno Y, Into T, Lowenstein CJ, Matsushita K. Nitric oxide regulates vascular calcification by interfering with TGF-signalling. Cardiovasc Res. 2008;77(1):221-230.
15. Massion PB, Pelat M, Belge C, Balligand JL. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A Mol Integr Physiol. 2005;142(2):144-150.
16. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007;42(2):271-279.
17. Smith RS Jr, Agata J, Xia CF, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci. 2005;76(21):2457-2571.
18. Molinari C, Uberti F, Grossini E, Vacca G, Carda S, Invernizzi M, Cisari C. la,25-Dihydroxycholecalciferol induces nitric oxide production in coltured endothelial cells. Cell Physiol Biochem. 2011; 27(6):661-668.
19. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myo-cardial infarction is inversely associated with plasma 25-hydroxyvi-tamin D3 levels: a community-based study. Int JEpidemiol. 1990; 19(3):559-563.
20. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174-1180.
21. Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H2O2 regulates cardiac myocytes phenotype via concentration-dependent activation of distinct kinase pathways. JMol Cell Cardiol. 2003;35(6):615-621
22. Han H, Long H, Wang H, Wang J, Zhang Y, Wang Z. Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 ratventricular cells: a novel pattern ofapoptosis and themechanism. Am J Physiol Heart Circ Physiol. 2004;286(6):H2169-H2182.
23. Rizzuto R, Pozzan T. Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev. 2006; 86(1):369-408.
24. Hoyer-Hansen M, Bastholm L, Szyniarowski P, et al. Control of macroautophagy by calcium, calmodulin-dependent kinase ki-nase-/3, and Bc1-2. Mol Cell. 2007;25(2):193-205.
25. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K. The role of autophagy in the heart. Cell Death Differ. 2009;16(1):31-38.
26. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroauthopagy in inflammation and infection. Discov Med. 2011;11(59):325-335.
27. Wang RC, Levine B. Calcipotriol induces autophagy in Hela cells and keratinocytes. J Invest Dermatol. 2011;131(4):990-993.
28. Hamacher-Brady A, Brady NR, Gottlieb RA. The interplay between pro-death and pro-survival signaling pathways in myocardial isch-emia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther. 2006;20(6):445-462.
29. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived fromumbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11): 2745-2756.
30. Sun HY, Wang NP, Kerendi F, et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intra-cellular Ca2+ overload. Am J Physiol Heart Circ Physiol. 2005; 288(4):H1900-H1908.
31. Forster K, Paul I, Solenkova N, et al. NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore byactivating p70S6 kinase. Basic ResCardiol. 2006; 101(4):319-326.
32. Dedkova EN, Blatter LA. Characteristics and function of cardiac mitochondrial nitric oxide synthase. JPhysiol. 2009;587(Pt4):851-872.
33. Uberti F, Caimmi PP, Molinari C, Mary D, Vacca G, Grossini E. Levosimendan modulates programmed forms of cell death through K(ATP) channels and nitric oxide. J Cardiovasc Pharmacol. 2011; 57(2):246-258.
34. Polidoro L, Properzi G, Marampon F, et al. Vitamin D protects human endothelial cells fromH2O2oxidantinjurythroughthe Mek/ Erk-Sirtl axis activation. JCardiovasc Transl Res. 2013;6(2):221-231.
35. Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther. 2005;106(2):147-162.
36. Foncea R, Carvajal C, Almarza C, Leighton F. Endothelial cell ox-idative stress and signal transduction. Biol Res. 2000;33(2):89-96.
37. Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis C. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz. 2003;28(7):628-638.
38. Pestana CR, Silva CH, Uyemura SA, Santos AC, Curti C. Impact of adenosine nucleotide translocase (ANT) proline isomerization on Ca2+-induced cysteine relative mobility/mitochondrial permeability transition pore. J Bioenerg Biomembr. 2010;42(4):329-335.